Workflow
AYJK(002172)
icon
Search documents
澳洋健康(002172) - 2014 Q2 - 季度财报
2014-08-25 16:00
Financial Performance - The company reported a revenue of ¥1,468,556,806.45, a decrease of 9.67% compared to the same period last year[18]. - The net profit attributable to shareholders was a loss of ¥45,531,128.64, representing a decline of 277.20% year-on-year[18]. - The net cash flow from operating activities was ¥141,317,047.51, down 42.80% from the previous year[18]. - The company's operating revenue for the reporting period was ¥1,468,556,806.45, a decrease of 9.67% compared to the same period last year[25]. - Operating costs amounted to ¥1,364,027,441.56, reflecting a reduction of 4.42% year-on-year[25]. - The company anticipates a net loss of between ¥60 million and ¥40 million for the first nine months of 2014, compared to a profit of ¥25.69 million in the same period last year[34]. - The company reported a gross margin of 6.79% in the chemical fiber industry, down from the previous year[28]. - The company reported a net loss of ¥58,451,829.79 compared to a net profit of ¥26,831,764.31 in the previous period, indicating a significant downturn[92]. - The basic and diluted earnings per share were both -¥0.08, down from ¥0.05 in the prior period[92]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,938,669,728.93, an increase of 2.89% compared to the end of the previous year[18]. - The total liabilities increased to CNY 2,170,442,690.33 from CNY 2,021,236,636.00, indicating a rise in financial obligations[86]. - The company's equity attributable to shareholders decreased to CNY 583,879,916.25 from CNY 637,616,164.89, reflecting a decline in retained earnings[86]. - The total current liabilities rose to CNY 2,129,610,287.23 from CNY 1,976,921,712.49, indicating increased short-term financial pressures[86]. - The total accounts receivable at the end of the period amounted to ¥75,369,114, with a bad debt provision of ¥5,396,437.8, representing 7.16% of the total[200]. Cash Flow - The net cash flow from investing activities improved by 76.01%, with a net outflow of ¥6,088,494.79 compared to a larger outflow in the previous year[25]. - The net cash flow from financing activities decreased by 46.12%, resulting in a net outflow of ¥103,028,452.87[25]. - Cash flow from operating activities generated a net cash inflow of ¥141,317,047.51, a decrease from ¥247,078,833.97 in the previous period[98]. - The total cash outflow for financing activities was 1,013,161,452.87, indicating a high level of financial obligations[99]. - The company’s cash inflow from operating activities was significantly lower than the previous period, indicating potential challenges in revenue generation[100]. Business Operations - The company’s main business, viscose staple fiber, accounted for 99.18% of total revenue[24]. - The viscose staple fiber market experienced a slight price decline, with prices stabilizing and slightly recovering in the second quarter[23]. - The company is focusing on cost reduction and efficiency improvement to enhance its competitive advantage in a challenging market environment[23]. - The company plans to optimize inventory management and adjust production strategies based on market trends[23]. - The company operates in the viscose staple fiber industry, focusing on the production and sales of viscose fibers, biodegradable fibers, and functional fibers[122]. Shareholder Information - The company will not distribute cash dividends or issue bonus shares for this period[4]. - The total number of ordinary shareholders at the end of the reporting period was 38,818[75]. - The largest shareholder, Aoyang Group Co., Ltd., holds 42.67% of the shares, with a total of 240,082,979 shares[75]. - The company has committed to ensuring that no more than 25% of its total shares will be transferred during the tenure of its major shareholder[65]. - The company has maintained compliance with its commitments regarding share transfers and has not faced any penalties or rectifications during the reporting period[68][69]. Research and Development - The company has established a research and development center for differentiated viscose products, which has led to the development of multiple patented technologies[29]. - The company plans to continue its market expansion efforts, focusing on enhancing its product offerings and technological advancements[113]. - The company has outlined strategies for potential mergers and acquisitions to further strengthen its market presence and operational capabilities[186]. Compliance and Governance - No significant changes in profit structure or major litigation issues were reported during the period[26][40]. - The company did not engage in any major transactions or events that require additional explanation during the reporting period[69]. - The financial report for the half-year period has not been audited[68]. - The company did not undergo any changes in its board of directors or senior management during the reporting period[81]. Accounting Policies - The financial statements are prepared based on the assumption of going concern and comply with the accounting standards issued by the Ministry of Finance[123][124]. - The company recognizes financial assets transferred to other parties based on the transfer of risks and rewards associated with those assets[137]. - The company conducts impairment testing on financial assets, recognizing impairment losses when the present value of expected future cash flows is less than the carrying amount[140]. - The company assesses deferred tax assets based on the likelihood of future taxable income to utilize temporary differences[178].
澳洋健康(002172) - 2014 Q1 - 季度财报
2014-04-28 16:00
Financial Performance - Revenue for Q1 2014 was ¥625,142,746.90, a decrease of 18.96% compared to ¥771,444,584.81 in the same period last year[8] - Net profit attributable to shareholders was -¥32,305,993.73, representing a decline of 294.20% from ¥16,635,092.10 year-on-year[8] - Basic earnings per share dropped to -¥0.06, a decrease of 300.00% compared to ¥0.03 in the previous year[8] - Operating profit decreased by 517.06% compared to the previous year, primarily due to lower total sales gross profit[20] - The company expects a net loss of between -60 million to -40 million CNY for the first half of 2014, compared to a net profit of 25.69 million CNY in the same period of 2013[26] - The decline in performance is attributed to a continuous drop in the market price of adhesive short fibers, while the upstream pulp price has decreased relatively less, leading to a decline in gross profit margin[26] - The company is facing challenges in product sales, which has contributed to the anticipated losses[26] - The company’s performance is expected to be negatively impacted by market conditions and pricing pressures in the adhesive short fiber sector[26] Cash Flow and Assets - Operating cash flow net amount was -¥65,501,730.23, down 135.77% from ¥183,099,726.97 in the same period last year[8] - Total assets at the end of the reporting period were ¥2,832,772,493.85, a slight decrease of 0.82% from ¥2,856,120,624.39 at the end of the previous year[8] - Cash flow from financing activities increased by 120.49% compared to the previous year, due to a higher net cash inflow from borrowings[21] Income and Expenses - The company reported a 72.35% increase in prepayments due to higher advance payments for raw materials[19] - Investment income increased by 100% year-on-year, attributed to losses from a subsidiary in the previous year[20] - The company experienced a 76.13% decline in other operating income, mainly due to lower subsidy income recognized in the current period[20] - Increased inventory levels due to sluggish sales have necessitated the company to make impairment provisions for inventory products[26] Commitments and Compliance - The company has committed to not transferring more than 25% of its shares during the tenure of its executives, ensuring compliance with this commitment[25] - The company has also committed to not selling more than 5% of its total shares through the securities trading system within a six-month period starting from March 28, 2014[25] - The company reported that all commitments made have been strictly adhered to during the commitment period[25] - The company has not reported any unfulfilled commitments or plans for future commitments[25] Management and Reporting - The company’s board chairman is Shen Xue Ru, who presented the report on April 29, 2014[27]
澳洋健康(002172) - 2013 Q4 - 年度财报
2014-03-21 16:00
Financial Performance - The company's operating revenue for 2013 was ¥3,277,439,678.62, a decrease of 7.74% compared to ¥3,552,361,540.76 in 2012[21] - The net profit attributable to shareholders for 2013 was ¥20,912,531.41, down 41.34% from ¥35,652,820.63 in the previous year[21] - The net cash flow from operating activities was ¥238,730,309.40, reflecting a decline of 56.14% from ¥544,264,366.22 in 2012[21] - The basic earnings per share for 2013 was ¥0.04, a decrease of 33.33% compared to ¥0.06 in 2012[21] - Total assets at the end of 2013 amounted to ¥2,856,120,624.39, a decrease of 3.13% from ¥2,948,288,007.40 at the end of 2012[21] - The net profit for Q1 2014 is expected to be negative, ranging from -25 million to -35 million RMB, compared to a net profit of 16.63 million RMB in Q1 2013[59] - The decline in performance is primarily due to the continuous drop in the price of viscose staple fiber, poor sales, and an increase in inventory requiring impairment provisions[59] Cash Flow and Investments - The company’s cash flow from operating activities decreased by 71.19% to CNY 1,304,968,398.37[35] - Cash and cash equivalents decreased by 129.99% compared to the previous year[36] - The net cash flow from investment activities was -¥96.18 million, worsening from -¥28.07 million in the previous year[171] - Cash inflow from financing activities increased to ¥1.69 billion, up 19.8% from ¥1.41 billion in the previous year[168] - The company paid ¥1.73 billion in debt repayments, slightly lower than ¥1.74 billion in the previous year[168] Assets and Liabilities - Total current assets amounted to CNY 1,124,699,018.88, an increase from CNY 1,086,137,990.74 in the previous year, reflecting a growth of approximately 3.5%[151] - Total non-current assets decreased to CNY 1,731,421,605.51 from CNY 1,862,150,016.66, indicating a decline of about 7%[152] - Total liabilities were reported at CNY 2,021,236,636.00, down from CNY 2,162,798,862.30, representing a reduction of approximately 6.5%[153] - Shareholders' equity increased to CNY 834,883,988.39 from CNY 785,489,145.10, showing an increase of about 6.3%[153] Production and Sales - The company increased production and sales of differentiated products, such as flame-retardant fibers, in response to market demand[26] - The company’s production volume increased by 9.70% to 285,738.68 tons[29] - The company's annual production capacity for viscose staple fiber is 300,000 tons, with a focus on differentiated viscose development to enhance product value[44] Research and Development - Research and development expenses amounted to CNY 4,283,207.13, representing 0.13% of operating revenue[33] - The company has established a research and development center with multiple patented technologies for differentiated products[44] - The company has invested 50 million RMB in R&D for new technologies aimed at enhancing production efficiency[105] Market Strategy and Competition - The viscose staple fiber industry is experiencing intense competition, leading to a focus on differentiated products to maintain profitability[52] - The company plans to increase the production and sales ratio of differentiated products in 2014, aiming to improve overall competitiveness[51] - The company plans to expand its market presence in Southeast Asia, targeting a 15% market share within the next three years[105] Governance and Compliance - The company has established a comprehensive governance structure in compliance with relevant laws and regulations, including the formulation of internal control rules[116] - The board of directors consists of specialized committees, enhancing decision-making processes and governance structure[119] - The company maintains compliance with the Company Law and relevant regulations from the China Securities Regulatory Commission[126] Shareholder Information - The total number of shareholders increased from 41,790 to 43,268 during the reporting period[90] - The largest shareholder, Aoyang Group Co., Ltd., holds 42.96% of the shares, amounting to 243,082,979 shares, with 160 million shares pledged[90][91] - The company has committed to not transferring more than 25% of its shares during the tenure of its major shareholders, with a long-term commitment to protect minority shareholders[77] Related Party Transactions - The total amount of related party transactions for the company reached 23.54 million yuan, with the largest transaction being the sale of electricity amounting to 2,247.91 million yuan, accounting for 49.61% of similar transactions[66] - The company maintains independence from related parties in terms of business, personnel, finance, assets, and institutions, ensuring that related party transactions do not affect its independence[66] Future Outlook - The company has set a performance guidance of 1.8 billion RMB in revenue for 2014, reflecting a growth target of 20%[105] - The company plans to continue expanding its market presence and investing in new technologies[178] - The financial performance indicates a positive outlook for future growth and profitability[178]